Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tangbi Prescription in Diabetic Distal Symmetric Polyneuropathy
NCT03010241Phase 1Unknown
- Sponsor
- Guang'anmen Hospital
- Start
- Jan 2017
- Primary completion
- Nov 2019
- Modality
- Drug Delivery Systems
01
Overview
Phase 1, randomised, double-blind trial in diabetic distal symmetric polyneuropathy (DSPN) comparing Tangbi Prescription with Placebo (2 arms). Primary endpoint: Michigan Diabetic Neuropathy Score at 6 months. Status: unknown.
02
Drugs
Tangbi
03
Conditions
diabetic distal symmetric polyneuropathy (DSPN)
Beyond the preview
Go deeper on NCT03010241.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03010241.